PROX1 has been reported to interact with a panel of genes implicated in glucose metabolism, including β-catenin 14 and DBC1 15, in CRC 11, 16, and PROX1 has been implicated in the metabolic adaptation of metastatic colon cancer cells 17. Here, PROX1 is linked to colorectal carcinoma.